Work

Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control

Year: 2025

Type: article

Source: Organic Process Research & Development

DOI: 10.1021/acs.oprd.5c00005

Authors: Qiang Yang, Ryan J. Linder, Yu Lu, Thomas J. Beauchamp, Timothy A. Woods, David A. Coates, Brandon J. Reizman, Jonas Y. Buser, Michael E. Laurila, Nicholas A. Magnus, Yongjie Yu, Lili Han, Ping Huang

Institution: Eli Lilly (United States)

Language: English

Topic: Protein purification and stability

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409087940

FWCI: 0.783

Cites: 38

Cited by: 3

Related to: 10